Developmental/Behavioral Disorders

Findings of a population-based cohort study indicate that a low Apgar score at 5 minutes in newborns is associated with a higher risk of attention-deficit/hyperactivity disorder (ADHD) in childhood.

A large number of positive screens for autism spectrum disorder (ASD) at 18 months in infants who were born very preterm actually may be because of cognitive and language delay, according to research presented at the 2011 Pediatric Academic Societies meeting in Denver.

Atomoxetine is well tolerated and reduces core attention-deficit/hyperactivity disorder (ADHD) symptoms in preschool children, according to a study reported in Pediatrics.

Two-thirds of children with attention-deficit/hyperactivity disorder (ADHD) have comorbid mental health or neurodevelopment disorders, according to a large survey reported online in Pediatrics.

A restricted elimination diet may be effective in reducing symptoms of attention-deficit/hyperactivity disorder (ADHD) in children, according to researchers from the Netherlands.

A new Harris Interactive-Health Day poll found that 52% of Americans believe that vaccines do not cause autism.

The care that children with attention-deficit/hyperactivity disorder (ADHD) receive under managed-care Medicaid programs has much room for improvement, a new study in the Journal of the American Academy of Child and Adolescent Psychiatry suggests.

Findings of a study conducted in Denmark have added to accumulating evidence that exposure to neonatal jaundice is associated with autistic disorders and other disorders of psychological development.

Although the exact cause of attention-deficit/hyperactivity disorder (ADHD) has not yet been determined, a new study provides evidence that tobacco and lead exposure may increase a child's risk of developing the condition.

Pharmacotherapy, namely the stimulant medications methylphenidate (MPH) and amphetamine (MAS) and the nonstimulant medication atomoxetine (Strattera), is the recommended treatment for attention-deficit/hyperactivity disorder (ADHD).

An article published in Contemporary Pediatrics 25 years ago instructed pediatricians on medications to treat attention deficit disorders (ADD). Their observations were so perceptive that, with a few tweaks, they could be republished as a 2009 update on attention deficit/hyperactivity disorder (ADHD).

The FDA has approved a new type of drug, an alpha-2A adrenergic receptor agonist, to treat ADHD in children as young as six.

Perhaps thanks to a lawsuit, some young children with autism may benefit from Blue Cross Blue Shield of Michigan's new initiative.

Teva is now selling generic versions of Shire Plc's ADHD drug Adderall XR in the US, years before its patent expires.

A new federal advisory panel on autism has released its first guidelines for autism research.

A landmark 1988 Lancet article featured exaggerated and falsified claims, to make the connection seem stronger than the study data suggested, according to the Times of London.

Young people with ADHD may be at increased risk of becoming addicted to tobacco, according to a report in the Journal of Pediatrics.

Tobacco smoke and lead exposure may be linked to a particularly high risk of ADHD, according to findings presented at the 2008 Annual Meeting of the Society for Developmental and Behavioral Pediatrics.

A small but significant percentage of US adults believe that child vaccines are a cause of autism, survey results show.

This article reviews major concepts contained in the AAP's 2007 autism spectrum disorders guidelines and toolkit, including screening, evaluation, management, and medication options.

A description of 11 books for children with autism and autism spectrum disorders.

Strong evidence against the association of autism with the measles, mumps, and rubella (MMR) vaccine has been presented in the September 4 PLoS ONE, reported study researchers.

The American Academy of Pediatrics (AAP) has stated it does not support the routine use of electrocardiogram (ECG) screening before initiating treatment with stimulants for children and adolescents with attention deficit hyperactivity disorder (ADHD).

ADHD diagnoses for children ages 6 to 17 have on average increased 3% per year from 1997 through 2006, according to the Centers for Disease Control and Prevention (CDC).

A reader comments on the lack of supporting evidence for the benefits of ADHD stimulants for children.